How to buy PRA Health Sciences stock (PRAH)

PRA Health Sciences is a diagnostics & research business based in the US. PRA Health Sciences shares (PRAH) are listed on the NASDAQ and all prices are listed in US Dollars. PRA Health Sciences employs 18,100 staff and has a trailing 12-month revenue of around $3.3 billion.

Our top picks for where to buy PRA Health Sciences stock

Buy PRA Health Sciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

PRA Health Sciences stock price (NASDAQ: PRAH)

Use our graph to track the performance of PRAH stocks over time.

PRA Health Sciences shares at a glance

• Key figures

Information last updated 2021-08-29.

52-week range	$0.00 - $0.00
50-day moving average more info button	$169.44
200-day moving average more info button	$149.58
Wall St. target price	$165.40
PE ratio more info button	50.5229
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$3.27

Is it a good time to buy PRA Health Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is PRA Health Sciences stock undervalued or overvalued?

Valuing PRA Health Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PRA Health Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

PRA Health Sciences's P/E ratio

PRA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 51x. In other words, PRA Health Sciences shares trade at around 51x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

PRA Health Sciences's PEG ratio

PRA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0426. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PRA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

PRA Health Sciences's EBITDA

PRA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $435.2 million.

The EBITDA is a measure of a PRA Health Sciences's overall financial performance and is widely used to measure a its profitability.

PRA Health Sciences financials

Revenue TTM	$3.3 billion
Operating margin TTM	9.1%
Gross profit TTM	$1.5 billion
Return on assets TTM	4.76%
Return on equity TTM	16.02%
Profit margin	6.4%
Book value	$24.03
Market Capitalization more info button	$10.7 billion

TTM: trailing 12 months

PRA Health Sciences share dividends

We're not expecting PRA Health Sciences to pay a dividend over the next 12 months.

PRA Health Sciences share price volatility

Over the last 12 months, PRA Health Sciences's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PRA Health Sciences's is 1.3272. This would suggest that PRA Health Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

PRA Health Sciences overview

PRA Health Sciences, Inc. , a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. It operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that allow clients to access and analyze Symphony Health and integrated third-party data.

Frequently asked questions

What percentage of PRA Health Sciences is owned by insiders or institutions?
Currently 0.231% of PRA Health Sciences shares are held by insiders and 96.628% by institutions. How many people work for PRA Health Sciences?
Latest data suggests 18,100 work at PRA Health Sciences. When does the fiscal year end for PRA Health Sciences?
PRA Health Sciences's fiscal year ends in December. Where is PRA Health Sciences based?
PRA Health Sciences's address is: 4130 ParkLake Avenue, Raleigh, NC, United States, 27612 What is PRA Health Sciences's ISIN number?
PRA Health Sciences's international securities identification number is: US69354M1080 What is PRA Health Sciences's CUSIP number?
PRA Health Sciences's Committee on Uniform Securities Identification Procedures number is: 69354M108